Neoadjuvant Treatment Modalities in Esophageal Cancer

NCT04821843 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Chemotherapy Effect
Chemoradiation
Surgery
Targeted Therapy
Immunotherapy
Esophagogastric Juction Cancer

Interventions

DRUG: Platinum based chemotherapy
DRUG: Paclitaxel based chemotherapy
RADIATION: Radiotherpay
PROCEDURE: Surgery
DRUG: Immunotherapy
DRUG: 5-FU Analog based chemotherpay
DRUG: Nimotuzumab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences